DigiPath Labs Successfully Completes Proficiency Testing for Cannabis Potency
PR Newswire - Fri Oct 09, 1:19PM CDT
DigiPath Labs, a subsidiary of DigiPath, Inc. (OTCBB and OTCQB: DIGP), recently successfully completed voluntary proficiency testing of its ability to detect cannabinoids and terpenoids, accurately identifying potency levels of five cannabinoids and 10 terpenoids in unknown samples. The testing was administered by Absolute Standards, Inc. of Hamden, CT, an independent third-party. "Potency testing is extremely important for patient care," explains Dr. Cindy Orser, the Chief Science Officer of DigiPath Labs. "The levels of each cannabinoid and terpenoid enable doctors and dispensaries to recommend products and dosages that will help relieve a patient's symptoms without going overboard. Third party confirmation of our potency testing provides further assurance to our customers as to the quality and reliability of our services."
DigiPath Labs CSO Cindy Orser Presents to DC Attorney General on Synthetic Cannabis and Need for Standardization
PR Newswire - Mon Oct 05, 11:11AM CDT
Cindy Orser, PhD, Chief Science Officer of DigiPath Labs, the cannabis testing subsidiary of DigiPath, Inc. (OTCQB: DIGP), recently gave a presentation before Washington, DC, Attorney General Karl A. Racine and others in charge of the District's medical cannabis program on the issues of synthetic cannabis, identifying cannabis strains, and the need for testing standardization. Dr. Orser was one of the representatives of the Coalition for Responsible Cannabis Production, which subsequently signed an agreement with Attorney General Racine to combat the dangers posed by synthetic drugs that many falsely assume are no more harmful than cannabis.
DigiPath Labs Continues to Attract New Clients, Signs Contract with MMJ Cultivator
PR Newswire - Wed Sep 30, 8:00AM CDT
DigiPath Labs, the cannabis testing subsidiary of DigiPath, Inc. (OTCQB: DIGP), continues to gain momentum in the medical cannabis community of Nevada. The company's dedication to setting the highest standard of cannabis testing accuracy and reliability is attracting growers, product makers, and dispensaries that want to ensure patient safety and comply with state laws. DigiPath Labs just signed a one-year exclusive contract to test dried plant material for a local grower.
Signal Bay Makes Strategic Acquisition in the $850M Cannabis Testing Market
ACCESSWIRE - Wed Sep 23, 8:20AM CDT
SEATTLE, WA / ACCESSWIRE / September 23, 2015 / Oregon has been on the forefront of the cannabis industry for many years. After legalizing medical marijuana back in 1998 and recreational marijuana last year, the state has been a pioneer when it comes to important issues like reprieve for prior crimes. Measure 91 promises to open up a $450 million market for the state by 2020, according to New Frontier Financials projections, creating jobs, raising tax revenue, and yielding opportunities for investors.
INSY: 25.65 (+0.64), GWPH: 87.75 (+0.45)
'Queen of Cannabis' Cheryl Shuman Returns to The National Marijuana News Show
PR Newswire - Thu Sep 17, 12:40PM CDT
The National Marijuana News Corp., a.k.a. TNMNews, a wholly owned subsidiary of DigiPath, Inc. (OTCBB and OTCQB: DIGP), recently posted its second exclusive interview with pioneering cannabis industry advocate Cheryl Shuman, known as the "Queen of Cannabis" or the "Martha Stewart of Marijuana." The video segments are available at www.tnmnews.com and on the TNMNews app, now available on iTunes and Google Play.
DigiPath Labs CSO Cindy Orser to Speak at Upcoming Cannabis World Congress & Business Exposition
PR Newswire - Mon Sep 14, 8:00AM CDT
Cindy Orser, PhD, Chief Science Officer of DigiPath Labs, the cannabis testing subsidiary of DigiPath, Inc. (OTCQB: DIGP), will present on the need for uniform cannabis testing standards at the upcoming Cannabis World Congress & Business Exposition (CWCBExpo) at the Los Angeles Convention Center. The second-annual CWCBExpo, to be held September 16-18, is the leading forum for members of the cannabis business community.
DigiPath Pushes for Uniform Standards in Cannabis Testing
ACCESSWIRE - Thu Sep 10, 11:53PM CDT
SEATTLE, WA / ACCESSWIRE / September 11, 2015 / The cannabis industry could reach $35 billion in size by 2020, if all 50 states legalized marijuana and the federal government ended prohibition, according to GreenWave Advisors. Despite the industry's explosive growth, state governments have been slow to implement consistent regulations when it comes to cannabis safety standards, while the federal government has remained all but absent from any cannabis-related discussions.
MRK: 50.95 (-0.07)
DigiPath Labs Provides Insight on Proposed Puerto Rico Medical Cannabis Law
PR Newswire - Wed Sep 09, 8:00AM CDT
DigiPath Labs, the cannabis testing subsidiary of DigiPath, Inc. (OTCQB: DIGP), recently expressed concerns that Puerto Rico's new state-run medical cannabis policy does not include third-party safety testing, a crucial assurance to patients that their medicine is safe. In an interview with Caribbean Business journal, DigiPath Labs Chief Science Officer Cindy Orser, PhD, explains the need for consistent standards in cannabis testing and notes that the proposed Puerto Rican medical cannabis law, in its current form, fails to embrace the requirement for independent quality assurance.
DigiPath Labs CSO Dr. Cindy Orser Calls for Uniform Standards for Cannabis Safety Testing
PR Newswire - Tue Sep 01, 10:59AM CDT
Dr. Cindy Orser, the Chief Science Officer of DigiPath Labs, the cannabis testing subsidiary of DigiPath, Inc. (OTCQB: DIGP), was recently interviewed by United Patients Group about the lack of consistency in today's medical cannabis testing industry. In her talk with the online resource for medical cannabis information, she explained that the state-to-state variations in cannabis laws are hurting patients because their lack of uniform requirements makes standardization impossible.
DigiPath Labs Clears the Way for Las Vegas' First Cannabis Dispensary
ACCESSWIRE - Fri Aug 21, 11:56AM CDT
SEATTLE, WA / ACCESSWIRE / August 21, 2015 / Nevada legalized medical marijuana in 2001, enabling patients to grow a maximum of 12 cannabis plants at home, but the first dispensary in Southern Nevada selling medical marijuana to the public opened just this month with the passing of Senate Bill 374. The bill clears the way for up to 66 dispensaries and 200 production facilities to operate in the Silver State under the direction of the Department of Health and Human Services.
DigiPath Labs Enables Opening of First Marijuana Dispensary in Las Vegas
PR Newswire - Wed Aug 19, 8:00AM CDT
DigiPath Labs, the cannabis testing subsidiary of DigiPath, Inc. (OTCQB: DIGP), has cleared the way for the opening of the first cannabis dispensary in Southern Nevada. The state-of-the-art cannabis testing facility performed extensive quality assurance testing on the first batch of cannabis harvested by Alternative Medicine Association and approved it for medical use. The green light from DigiPath Labs should expedite the opening of Euphoria Wellness, which plans to open in Las Vegas soon, and is exciting news for patients who eagerly await access to safe, reliable medicinal cannabis.
DigiPath is Well-Positioned as Nevada Considers Adult-Use Legalization
ACCESSWIRE - Mon Aug 17, 10:16AM CDT
SEATTLE, WA / ACCESSWIRE / August 17, 2015 / DigiPath Inc. (OTCQB: DIGP), a leading provider of laboratory testing, education programs, and unbiased news coverage to the burgeoning cannabis industry, has become a leading player in Nevada's medical marijuana market with the opening of its testing laboratory earlier this year. Equipped with state-of-the-art analytical instrumentation and operated under the direction of Cindy Orser, Ph.D., the facility provides growers and manufacturers with reliable testing data.
DigiPath Labs Completes Validation of Romer Labs Food-Borne Pathogen and Mycotoxin Testing Solutions
PR Newswire - Thu Aug 13, 8:00AM CDT
DigiPath Labs, the cannabis testing subsidiary of DigiPath, Inc. (OTCQB: DIGP), in cooperation with True North Laboratory, has completed validation of four Romer Labs food safety testing solutions for cannabis. DigiPath Labs intends to use Romer Labs' rapid diagnostic test kits to screen for food-borne pathogens and quantify mycotoxins present in cannabis.
DigiPath's Marketing Experiment Grows into a Popular Media Presence
ACCESSWIRE - Mon Aug 10, 8:45AM CDT
SEATTLE, WA / ACCESSWIRE / August 10, 2015 / DigiPath Inc. (OTC: DIGP) is a digital pathology company that operates within the cannabis testing industry after the opening of its Las Vegas laboratory in June. With GreenWave Advisors calling cannabis testing the most attractive subset of the industry, the company is well-positioned to capitalize on an $850 million market opportunity by 2020, with plans to expand within Nevada and into additional states that have legalized marijuana.
The National Marijuana News Releases Convenient App for On-the-Go Listening on iOS and Android
PR Newswire - Mon Aug 10, 8:00AM CDT
The National Marijuana News Corp., a wholly owned subsidiary of DigiPath, Inc. (OTCBB and OTCQB: DIGP), has just released an app that brings the popular unbiased marijuana news program directly into the pockets of listeners. The TMN News app is now available in the iTunes and Google Play stores for $.99.
Meeting With Attorney Generals Culminates in Call for National Standards
ACCESSWIRE - Mon Aug 03, 12:15PM CDT
SEATTLE, WA / ACCESSWIRE / August 3, 2015 / Several marijuana business owners recently sat down with 20 attorney generals from across the country to discuss issues surrounding the cannabis industry. The group agreed to start work on a "Code of Responsible Practices" to help govern cannabis companies and promote the trade, despite the fact that many of the attorney generals came from states that did not have existing legal medical or recreational marijuana programs in place.
DigiPath Labs Partners with Romer Labs to Validate Food-Borne Pathogen and Mycotoxin Testing Solutions for Cannabis
PR Newswire - Tue Jul 28, 5:00AM CDT
DigiPath Labs, the cannabis testing subsidiary of DigiPath, Inc. (OTCQB: DIGP), is combining efforts with True North Laboratory of Ann Arbor, Michigan, and Romer Labs, a leading global supplier of diagnostic solutions for food-borne pathogens, to investigate the applicability of utilizing Romer Labs' rapid diagnostic test kits to screen for food-borne pathogens and quantify mycotoxins present in cannabis.
DigiPath Labs Advocating for Cannabis Industry Standards that Promote Public Safety and Health
PR Newswire - Thu Jul 23, 8:00AM CDT
DigiPath, Inc. (OTCBB and OTCQB: DIGP), the independent cannabis testing and media firm, has joined the Coalition for Responsible Cannabis Production (CRCP), a nationally focused industry standards and production protocols organization.
AP Story Highlights Need for Cannabis Testing
ACCESSWIRE - Wed Jul 22, 7:31AM CDT
SEATTLE, WA / ACCESSWIRE / July 22, 2015 / Microscopic bugs and mildew are becoming a multi-million dollar crisis for many marijuana growers, which have led many of them to turn to industrial-strength chemicals that are raising concerns over safety, according to the Associated Press.
DigiPath (DIGP) Well Positioned to Take Advantage of $850M Cannabis Testing Market
ACCESSWIRE - Thu Jul 16, 8:00AM CDT
WHITEFISH, MT / ACCESSWIRE / July 16, 2015 / There are many different ways to profit from the burgeoning cannabis industry, ranging from GrowBLOX Sciences Inc.'s (OTCQB: GBLX) growing solutions to Medbox Inc.'s (OTCQB: MDBX) dispensing technologies to Cannabis Science Inc.'s (OTCQB: CBIS) focus on the medicinal properties of the plant, but cannabis testing could be the most compelling.